US Stocks
/
Perspective Therapeutics, Inc. Share Price
Perspective Therapeutics, Inc. Share Price

Perspective Therapeutics, Inc. Share Price

AMEX: CATX | Micro Cap
$2.71
+$0.25 (10.16%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Perspective Therapeutics, Inc. Stock Performance

Open
$2.46
Prev. Close
$2.46
Circuit Range
N/A
Day Range
$2.38 - $2.73
Year Range
$1.96 - $6.16
Volume
1,46,190
Average Traded
$2.59

Perspective Therapeutics, Inc. Share Price Today

As of 9 October 2026, Perspective Therapeutics, Inc.'s share price is $2.71. The stock opened at $2.46, compared to its previous close of $2.46. During today's trading session, Perspective Therapeutics, Inc.'s share price traded between $2.38 and $2.73, with an average price of $2.55. Over the past 52 weeks, the stock has recorded a high of $6.16 and a low of $1.96. In terms of performance, Perspective Therapeutics, Inc.'s share price has declined by 30.51% over the last six months and is down 0.73% on a year-on-year basis.

Perspective Therapeutics, Inc. Share Price Chart

$2.38$2.73
L
Show Current Price
H

Perspective Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$200.03M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.02
Revenue (TTM)
$880.00M
Return On Equity (TTM)
-35.95%
Profit Margin
-11718.18%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-3.16%

Perspective Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.21$0.04$0.08$0.08
Net Profit-$25.97-$37.49-$26.19-$26.79
Net Profit Margin-12366.67%-93725.00%-32737.50%-33487.50%
Income ChangeN/A-44.36%30.14%-2.29%

Perspective Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$1.43$1.45$0.88
Net Profit-$46.51-$79.28-$103.12
Net Profit Margin-3252.45%-5467.59%-11718.18%
Income ChangeN/A-70.46%-30.07%

About Perspective Therapeutics, Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Perspective Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.69
$2.71
-1.09%
Sep 2026
$3.16
$2.75
-13.41%
Aug 2026
$2.88
$3.17
+9.69%
Jul 2026
$3.43
$2.89
-15.12%
Jun 2026
$3.87
$3.40
-13.69%
May 2026
$3.90
$3.94
+1.15%
Apr 2026
$4.16
$3.90
-6.47%
Mar 2026
$5.12
$4.17
-22.63%
Feb 2026
$4.14
$5.39
+42.59%
Jan 2026
$2.75
$3.78
+37.45%
Dec 2025
$2.29
$2.75
+16.53%
Nov 2025
$2.75
$2.36
-13.55%

CATX Share Price FAQs

What is Perspective Therapeutics, Inc. share price today?

chevron-up
Perspective Therapeutics, Inc. share price today is $2.71 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Perspective Therapeutics, Inc. stock?

chevron-up
The 52 week high of Perspective Therapeutics, Inc. stock is $6.16, while the 52 week low is $1.96 as of 9 Oct '26.

What is CATX's market capitalisation today?

chevron-up
CATX market capitalisation is $200.03M as of October 9, 2026, at 4:47 pm IST.

What is CATX's net income for the last quarter?

chevron-up
CATX's net income for the last quarter is -26.79B USD.

What is the 5 year returns of CATX?

chevron-up
The 5 year returns of CATX is -55.86% as on 9 Oct '26.

What is the high & low stock price of CATX today?

chevron-up
CATX stock price hit a high of $2.73 and low of $2.38 as of 9 Oct '26.

Can I buy CATX shares in India?

chevron-up
Yes. You can buy CATX in India by opening an international trading account.